The freezing achieves its effect not only by knocking out the fluid-producing cells in the stomach wall, but also by killing the network of vagal nerve endings that carry messages .
EnteroMedics Inc. (ETRM) Broke Out To A 10-Month High On Study Results EnteroMedics Inc. (ETRM) announced results from its 5 year ReCharge Pivotal Trial of VBLOC vagal blocking therapy for the treatment of obesity Tuesday morning. Patients in the VBLOC group achieved excess weight loss of 25%, or 10% total body weight loss, compared to 12% excess weight loss, or 4% total body weight loss for control group patients.
Dec. 4, 2013 - RTT News